Search
Research
Roswell Park-University of Chicago Ovarian Cancer SPORE Clinical Trials
… contact the Principal Investigator (Clinical), Emese Zsiros, MD, PhD, FACOG . Upcoming clinical trials A Phase … contact the Principal Investigator (Clinical), Emese Zsiros, MD, PhD, FACOG . Upcoming clinical trials A Phase …
Clinical Trial
A Phase 1, First-in-Human, Open-Label, DoseEscalation and Expansion Study of IMGN151 (anti-FR-alpha antibody drug conjugate) in Adult Patients with Recurrent Gynaecological Cancers
… in Adult Patients with Recurrent Gynaecological Cancers I Zsiros, Emese IIMGN151-1001 is a Phase 1, first in human, …
Clinical Trial
Randomized Phase 2 Clinical Trial of Pembrolizumab Combined with Bevacizumab with or without Agonist Anti-CD40 CDX-1140 in Patients with Recurrent Ovarian Cancer
… CDX-1140 in Patients with Recurrent Ovarian Cancer II Zsiros, Emese This phase II trial tests whether pembrolizumab …
Department of Immunology Faculty
… Professor of Oncology Department of Immunology Emese Zsiros, MD, PhD, FACOG Associate Professor of Oncology …
Blog Post
Coping with hair loss: Jerrolynn's story
… oncologists Katherine LaVigne Mager, MD, FACOG and Emese Zsiros, MD, PhD, FACOG. “Dr. Mager is a godsend and Dr. Zsiros was my first doctor here and integral in discovering … oncologists Katherine LaVigne Mager, MD, FACOG and Emese Zsiros, MD, PhD, FACOG. “Dr. Mager is a godsend and Dr. …
Clinical Trial
Randomized Phase 2 Trial of APL-2 with Pembrolizumab vs. APL-2 with Pembrolizumab and Bevacizumab vs. Bevacizumab alone in Patients with Recurrent Ovarian Cancer and Persistent Malignant Effusion
… Ovarian Cancer and Persistent Malignant Effusion II Zsiros, Emese This phase II trial studies the effect of APL-2 …
Clinical Trial
NRG-GY036: A Phase III Trial of One vs. Two Years of Maintenance Olaparib, With or Without Bevacizumab, in Patients With BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum Based…
… Following Response to First Line Platinum Based… III Zsiros, Emese This phase III trial compares the effect of …
News
Roswell Park Team Demonstrates Safe Approach for Dramatically Reducing Use of Opioids Following Surgery
… patients undergoing surgery, gynecologic oncologist Emese Zsiros, MD, PhD, FACOG , proposed a new pain-management … or recovery at all,” says study Senior Author Dr. Zsiros, Associate Professor of Oncology in the Department of … patients undergoing surgery, gynecologic oncologist Emese Zsiros, MD, PhD, FACOG , proposed a new pain-management …
Tumor Immunology & Immunotherapy Program Members
… Chair, Department of Immunology View the Abrams Lab Emese Zsiros, MD, PhD, FACOG Associate Professor of Oncology …
Research
Roswell Park-University of Chicago Ovarian Cancer SPORE Faculty and Staff
… Core Roswell Park Comprehensive Cancer Center Emese Zsiros, MD, PhD, FACOG Co-Leader (Clinical), Individual … Core Roswell Park Comprehensive Cancer Center Emese Zsiros, MD, PhD, FACOG Co-Leader (Clinical), Individual …